Published in

Lippincott, Williams & Wilkins, Transplantation, 1(100), p. 116-125, 2016

DOI: 10.1097/tp.0000000000000965

Links

Tools

Export citation

Search in Google Scholar

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

Journal article published in 2016 by Edward K. Geissler, Andreas A. Schnitzbauer, Carl Zülke, Philipp E. Lamby, Andrea Proneth, Christophe Duvoux, Patrizia Burra, Karl-Walter Jauch, Markus Rentsch, Tom M. Ganten, Jan Schmidt, Utz Settmacher, Michael Heise, Giorgio Rossi, Umberto Cillo and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

We investigated whether sirolimus-based immunosuppression improves outcomes in liver transplantation (LTx) candidates with hepatocellular carcinoma (HCC).